Concepedia

Author

Kerstin Wimmer

Medical University of ViennaORCID

Also Known As

Austin D. Williams, K Wimmer, K. Wimmer, Kerstin Wimmer

56

Publications

852

Citations

13

H-Index

26

Concepts

All Affiliations

Medical University of ViennaComprehensive Cancer Center ViennaInnsbruck Medical UniversityAustrian Breast & Colorectal Cancer Study GroupParacelsus Medical University
KW

About

Kerstin Wimmer is an author at Medical University of Vienna specializing in medicine, oncology, and patient safety.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

49

2

Engineering

1

1

13

3

Health Sciences

1

1

20

4

Nursing

1

1

29

5

Chemical Engineering

1

1

13

Kerstin Wimmer

×

9

Publications

605

Citations

9

H-Index

YearCitations

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

Stephen R Knight, Riinu Pius, Thomas M Drake,

The Lancet

2021

283

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

Michael Gnant, Florian Fitzal, Gabriel Rinnerthaler,

New England Journal of Medicine

2021

151

Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival

Kerstin Wimmer, Michael Bolliger, Zsuzsanna Bagó-Horváth,

Annals of Surgical Oncology

2019

44

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

Stephen R Knight, Catherine A. Shaw, Riinu Pius,

The Lancet Global Health

2022

29

Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases

Kerstin Wimmer, Christoph Schwarz, Carmen Szabó,

Annals of Surgical Oncology

2016

25

Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer

Maximilian Marhold, Simon Udovica, A. Halstead,

OncoImmunology

2023

24

Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial.

Michael Gnant, Sophie Frantal, Georg Pfeiler,

Journal of Clinical Oncology

2022

20

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Kerstin Wimmer, Monika Sachet, Cristiano Ramos,

Journal of Experimental & Clinical Cancer Research

2023

16

Characterization of Gun Propellants by Long‐Term Mass Loss Measurements

Moritz Heil, Kerstin Wimmer, Manfred A. Bohn

Propellants Explosives Pyrotechnics

2017

13

Page 1